Nanotech safety
This article was originally published in The Rose Sheet
Executive Summary
"Many nanotech companies and laboratories believe nanoparticles - specks of matter that are smaller than living cells - may pose specific environmental and health risks to workers," according to a Nov. 13 release from the International Council on Nanotechnology (ICON). The multi-stakeholder group acknowledges that risks to workers - who represent the front lines of the nanotech revolution and interact with the materials in their raw form - are likely greater than those to consumers. However, the research at issue - commissioned by ICON from the University of California, Santa Barbara, which surveyed 64 organizations across the globe - could be employed by activists as evidence that sunscreens and cosmetics containing engineered nanoparticles demand more intensive study and stricter FDA regulation (1"The Rose Sheet" May 22, 2006, p. 3). The report is available at 2http://icon.rice.edu...
You may also be interested in...
Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.